Stage Cell Therapeutics
Launch date
Market cap
-
Enterprise valuation
€20m (Public information from May 2015)
Company register number HRB 242321 (München)
Göttingen Lower Saxony (HQ & founding location)
Financials
Estimates*
| EUR | 2017 | 2020 | 2021 |
|---|---|---|---|
| Revenues | <1m | 5.6m | 3.0m |
| % growth | - | - | (46 %) |
| EBITDA | (11.4m) | (26.6m) | (34.3m) |
| % EBITDA margin | (1211 %) | (473 %) | (1126 %) |
| Profit | (12.1m) | (27.7m) | (35.6m) |
| % profit margin | (1282 %) | (493 %) | (1169 %) |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
$22.0m Valuation: $22.0m | Acquisition | ||
| Total Funding | - | ||